Privia Health Group financials
$19.62−1.26%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $632.6M | $603.8M | $541.2M | $580.4M | $521.2M | $480.1M | $460.9M | $437.9M | $422.3M | $415.2M | $440.8M | $417.3M |
| Gross profit | $563.3M | $535.4M | $474.3M | $519.0M | $456.2M | $420.6M | $401.1M | $381.9M | $365.2M | $361.2M | $388.4M | $367.0M |
| Gross margin | 89.0% | 88.7% | 87.6% | 89.4% | 87.5% | 87.6% | 87.0% | 87.2% | 86.5% | 87.0% | 88.1% | 87.9% |
| Operating income | $512.3M | $482.5M | $435.9M | $469.6M | $409.3M | $380.0M | $358.4M | $342.3M | $327.6M | $823.0K | $350.8M | $330.8M |
| Net income | $9.0M | $3.1M | $9.2M | $6.9M | $2.7M | $4.2M | $4.4M | $3.5M | $3.5M | $3.0M | $2.8M | $5.6M |
| Net margin | 1.4% | 0.5% | 1.7% | 1.2% | 0.5% | 0.9% | 1.0% | 0.8% | 0.8% | 0.7% | 0.6% | 1.4% |
| Diluted EPS | $0.07 | $0.02 | $0.07 | $0.05 | $0.02 | $0.03 | $0.03 | $0.03 | $0.03 | $0.02 | $0.02 | $0.05 |
| EBITDA | $515.6M | $485.8M | $438.6M | $472.4M | $411.9M | $381.9M | $360.2M | $344.1M | $329.5M | $2.6M | $350.8M | $332.5M |
| Operating cash flow | $1.1M | -$49.5M | $127.5M | $52.0M | $8.0M | -$24.1M | $74.8M | $33.2M | $34.5M | -$33.1M | $64.1M | $22.5M |
| Free cash flow | $1.1M | -$49.5M | $127.5M | $52.0M | $8.0M | -$24.1M | $74.8M | $33.2M | $34.5M | -$33.1M | $64.1M | $22.5M |
| Diluted shares | 131.8M | 130.9M | 130.6M | 128.8M | 128.4M | 127.8M | 126.3M | 125.8M | 125.3M | 125.1M | 124.9M | 124.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $412.2M | $419.5M | $479.7M | $441.4M | $390.1M | $469.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.49B | $1.42B | $1.37B | $1.35B | $1.27B | $1.18B |
| Total liabilities | $650.5M | $612.0M | $578.4M | $588.2M | $539.0M | $474.0M |
| Shareholders' equity | $838.1M | $805.9M | $790.9M | $762.8M | $733.5M | $709.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology